Worldwide Clinical Trials Expands Clinical Pharmacology Unit
Upgrades include end-of-life equipment replacements and relocation.
Worldwide Clinical Trials has announced an expansion of the pharmacy at its Clinical Pharmacology Unit (CPU) in San Antonio, Texas, according to a company press release.1 In addition to equipment upgrades, expansion efforts focused on operational demand, workplace demand, and employee engagement with the overall goal of enhancing customer experience. Completed in January 2024, the expanded pharmacy provides customers with streamlined processes, as well as decreased timelines and costs.
“A common thread among our Worldwide team members is a passion to take care of our customers—we’re always looking for ways to improve our partnerships,” said Mike Mencer, executive vice president and general manager, early phase, Worldwide Clinical Trials in the press release. “As part of an ongoing $5 million upgrade to our CPU, this expansion aligns with our culture of quality and our dedication to continuous improvement and innovation to meet our customers’ growing needs as we work together to improve the lives of patients around the world.”
Worldwide’s CPU, a 200-bed, fit-for-purpose facility, has been in operation since 2005. Within the unit, studies are conducted in healthy volunteers, patients, and specialty populations. The CPU is conveniently located one hour from Worldwide’s Bioanalytical Center of Excellence, offering an approach that benefits customers through streamlined vendor management, consistent standards, technical expertise, and overall efficiencies such as sample transfer and rapid processing.
“Expanding our pharmacy in size enables us to expand in volume, providing additional opportunities and efficiencies for our customers,” said Lona Sheeran, senior vice president, clinical operations, early phase, Worldwide Clinical Trials in the press release. “We can now manufacture onsite, in real time, for Phase I studies per FDA guidance, allowing our customers the option to pivot on their dose while their study is ongoing. This service is unique and can save our customers thousands of dollars and months of time—a huge advantage in this fast-paced industry.”
Reference
- Worldwide Clinical Trials Expands Clinical Pharmacology Unit Pharmacy to Enhance Customer Experience; Adds Efficiencies and Decreases Timelines. News release. February 21, 2024. Accessed February 21, 2024. https://www.businesswire.com/news/home/20240221954891/en
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
